A Study of Topical Danazol for the Treatment of Pain Associated With Fibrocystic Breast Disease (FP1198-001)
This study has been completed.
Sponsor:
FemmePharma Global Healthcare, Inc.
Information provided by:
FemmePharma Global Healthcare, Inc.
ClinicalTrials.gov Identifier:
NCT00744276
First received: August 28, 2008
Last updated: May 25, 2010
Last verified: May 2010
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | June 2009 |
| Primary Completion Date: | April 2009 (Final data collection date for primary outcome measure) |
| Certification or Request for Extension to Delay Results Received: | May 25, 2010 |